Business Wire

Vectara Launches Factual Consistency Score Powered by Upgraded Hughes Hallucination Evaluation Model to Enhance Transparency in GenAI Responses

Share

Vectara, the trusted Generative AI product platform, announced the inclusion of a Factual Consistency Score (FCS) for all generative responses based on an evolved version of the groundbreaking Hughes Hallucination Evaluation Model (HHEM)—the #1 hallucination detection model on Hugging Face with 100,000+ downloads since its launch last November. The associated Hallucination Leaderboard is now the industry standard for how LLMs benchmark their average factual consistency. Vectara’s end-to-end Retrieval Augmented Generation-as-a-service (RAGaaS) platform is setting a new standard as an industry-first feature for GenAI response transparency by providing real-time end-to-end RAG observability. This innovative metric provides unprecedented visibility into the factual consistency of summarized responses within Vectara’s RAGaaS platform, empowering users to set personalized thresholds for response acceptance based on a detailed accuracy score.

With average hallucination rates of LLMs on the market ranging from 3% to 16.2%, the risk of unknown inaccuracies in their response remains a major concern, preventing widespread business adoption of this powerful technology. Vectara mitigates this ambiguity for enterprises by providing a Factual Consistency Score grading the likelihood that the generated response is a hallucination or not. Only with a standardized, scientifically calculated method for grading responses can businesses responsibly introduce GenAI into business critical applications. Users have the ability to set thresholds for response acceptance based on a detailed accuracy score, giving product teams the flexibility to act on this information according to their preferences.

Vectara’s Factual Consistency Score is a groundbreaking tool in GenAI, setting a new benchmark for real-time hallucination detection and offering superior performance, affordability, and speed, thus marking a significant leap forward in trust. Its efficiency and effectiveness enable businesses to deploy GenAI into critical product use cases without being worried about exposure to liabilities that might arise from hallucinated responses.

Vectara's Factual Consistency Score equips developers with the capability to refine and enhance a wide range of applications, from internal Q&A systems to the quality of interactions with end consumers. The strength of this score lies in its calibration, making it interpretable as a direct probability—for instance, a score of 0.98 indicates a 98% probability of factual consistency. This contrasts sharply with many contemporary ML classifiers that disregard calibration, thus sacrificing clarity and direct interpretability.

"Integrating Vectara's Factual Consistency Score into the Yobi app will revolutionize how we handle AI transparency and accuracy for business use cases. By providing visibility and accountability into answers provided by our platform, we can stay true to our commitment to responsible AI that enterprises can depend on,” said Ahmed Reza, Founder and CEO of the Yobi app. “As a Co-Innovate Partner with Vectara, we're thrilled to see such advanced technology directly incorporated into the Vectara platform.”

The advanced HHEM that powers the Factual Consistency Score gives greater visibility than previously released open-sourced versions, offering enhanced accuracy and extended language support. This initiative is part of Vectara's commitment to transparency and control, empowering businesses with the autonomy to manage AI responses effectively.

"Just as we were early in pioneering RAG to enhance the relevance and quality of generated content, we are once again at the forefront of responsible AI by being completely open about our efforts to mitigate hallucinations in Generative AI," said Amr Awadallah, co-founder and CEO of Vectara. "By providing our customers with real-time access to factual consistency scores, we're not just engineering trust; we're handing over the control, enabling them to make informed decisions on how to utilize the responses generated by our RAGaaS platform."

About Vectara

Vectara is an end-to-end platform for embedding powerful generative AI features into applications with extraordinary results. As an end-to-end Retrieval Augmented Generation (RAG) platform, Vectara delivers the shortest path to a correct answer/action through a safe, secure, and trusted entry point. Vectara never trains on your data, allowing businesses to embed generative AI capabilities without the risk of data or privacy violations. To learn more, visit vectara.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Carly Bourne
carly@bulleitgroup.com
423-443-0449

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)17.9.2025 22:46:00 EEST | Press release

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Commission (EC) has approved ROMVIMZA™ (vimseltinib) in the European Union (EU) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability1. “The European Commission’s approval of vimseltinib for TGCT is a significant milestone for Deciphera, ONO, and TGCT patients across the European Union who are in need of a non-invasive treatment option. We are excited to leverage our global commercial infrastructure to bring vimseltinib to these patients,” said Ryota Udagawa, President and Chief Executive Officer of Deciphera. “We look forward to working with health authorities to ensure all eligible patients who can benefit from vimseltinib have access as quickly as p

Northern Escape Heli-Skiing Sees Global Surge in Demand as Adventurers Seek Canada’s Legendary Powder17.9.2025 19:09:00 EEST | Press release

Luxury adventure travel continues accelerating, with analysts projecting ~7.6% annual growth through 2030 [1][5]. Meanwhile, global tourism reached record highs in 2024 [2], and ski tourism is above pre-pandemic norms [3]. Northern Escape Heli-Skiing (NEH), named World’s Best Heli-Ski Operator by the World Ski Awards [4] in 2022, 2023, and 2024, continues to welcome a truly international mix of guests each winter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909723150/en/ Global Appeal Post-pandemic travellers prioritize remote, nature-led adventures and privacy-forward itineraries [1][3]. Adventure tourism is on a sharp upswing globally [5], while research highlights how social media and influencer content accelerate demand for marquee mountain experiences [7]. At the same time, heli-sports are forecast to expand steadily across Canada, Europe, APAC, and South America [8]. World’s Best Heli-Ski NEH operates in BC’s Ske

Bacardi Announces Internal Leadership Moves Within People and Supply Chain Organizations17.9.2025 17:35:00 EEST | Press release

Bacardi Limited, the world’s largest privately held international spirits company, announces several internal moves, underscoring the company’s global approach to leadership development and a commitment to talent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917778482/en/ Bacardi announces new roles for Dave Ingram and Nicole Zukowski. Dave Ingram has been appointed to the role of Chief People & Business Transformation Officer, responsible for delivering the next chapter for building an organization that is fit for the future. In this role, Dave will continue to prioritize talent management, succession planning, performance management, and capability building which are core to setting a legacy of more than 163 years for the success of generations to come. Dave, a member of the Bacardi Global Leadership Team, most recently served as Chief Supply Chain Officer, where he led the end-to-end supply chain for the company’s po

Andersen Consulting Adds Collaborating Firm Charter17.9.2025 16:30:00 EEST | Press release

Andersen Consulting expands its digital transformation capabilities through a Collaboration Agreement with Charter, a Canadian consulting firm that specializes in IT strategy, managed services, and application delivery. Established in 1997, Charter delivers technology projects with a business-first mindset and deep technical expertise, offering IT advisory, cloud infrastructure, cybersecurity, application development, project delivery, and business architecture. Charter supports traditional enterprise, government, service provider, and mid-market clients with implementation, network infrastructure, and customer-facing applications—delivered through a lifecycle approach from strategy to execution. “Our goal at Charter has always been to remove the complexity from IT and help organizations move with confidence,” said Kelly Michell, president of Charter. “Our collaboration with Andersen Consulting enables us to bring our integrated, business-aligned solutions to new markets and continue d

Wildix and RoboReception’s Joint AI Rollout Eliminates Missed Calls, Unlocking £9 Million in New Patient Value Across UK Healthcare17.9.2025 16:10:00 EEST | Press release

Wildix, a global leader in AI-powered business communications solutions, and RoboReception, one of the UK’s fastest-growing healthcare software providers, today announced results from an AI rollout reshaping patient access and practice economics. Since May 2025, the joint 24/7 AI receptionist has answered over 50,000 patient calls with zero missed, converting them into £9 million in new patient revenue and returning more than 2,000 hours to clinical care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917199595/en/ Wildix and RoboReception AI Rollout Unlocks £9M in Patient Value, Handles 50,000 Calls with Zero Missed Since May 2025 Delivered with Wildix reseller Focus CX, the rollout shows how agentic voice automation relieves frontline pressure, improves patient experience and provides measurable value. Missed calls remain one of healthcare’s hidden drains. Over a third of new patient calls go unanswered and most never c

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye